MX2010002039A - Estereoisomero de carbamato. - Google Patents

Estereoisomero de carbamato.

Info

Publication number
MX2010002039A
MX2010002039A MX2010002039A MX2010002039A MX2010002039A MX 2010002039 A MX2010002039 A MX 2010002039A MX 2010002039 A MX2010002039 A MX 2010002039A MX 2010002039 A MX2010002039 A MX 2010002039A MX 2010002039 A MX2010002039 A MX 2010002039A
Authority
MX
Mexico
Prior art keywords
sub
stereoisomer
carbamate
carbamate stereoisomer
bronchodilator
Prior art date
Application number
MX2010002039A
Other languages
English (en)
Spanish (es)
Inventor
H Scott Wilkinson
Craig R Abolin
William K Mcvicar
Paul Mcglynn
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of MX2010002039A publication Critical patent/MX2010002039A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MX2010002039A 2007-08-28 2008-08-28 Estereoisomero de carbamato. MX2010002039A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96639107P 2007-08-28 2007-08-28
PCT/US2008/074643 WO2009029717A1 (en) 2007-08-28 2008-08-28 Carbamate stereoisomer

Publications (1)

Publication Number Publication Date
MX2010002039A true MX2010002039A (es) 2010-03-25

Family

ID=39967298

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002039A MX2010002039A (es) 2007-08-28 2008-08-28 Estereoisomero de carbamato.

Country Status (12)

Country Link
US (2) US7718822B2 (enExample)
EP (1) EP2190813B1 (enExample)
JP (1) JP5529740B2 (enExample)
KR (1) KR20100065303A (enExample)
AR (1) AR071045A1 (enExample)
AU (1) AU2008293444B2 (enExample)
CA (1) CA2696922C (enExample)
ES (1) ES2430338T3 (enExample)
MX (1) MX2010002039A (enExample)
NZ (1) NZ583202A (enExample)
TW (1) TWI465416B (enExample)
WO (1) WO2009029717A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718822B2 (en) * 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
US8501994B2 (en) * 2007-08-28 2013-08-06 Sunovion Pharmaceuticals Inc. Acetamide stereoisomer
CN112279776B (zh) * 2020-11-02 2022-09-02 扬州中宝药业股份有限公司 一种合成阿福特罗游离碱的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657319A (en) * 1970-05-05 1972-04-18 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols
DE2115926C3 (de) 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1415256A (en) 1972-02-05 1975-11-26 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzyl alcohol derivatives
DE2305092A1 (de) 1972-02-05 1973-08-16 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzylalkoholderivate
JPS4880523A (enExample) * 1972-02-05 1973-10-29
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
JPS599542B2 (ja) * 1980-06-11 1984-03-03 山之内製薬株式会社 新規な３−アシルアミノ−４−ヒドロキシ−α−（アラルキルアミノメチル）ベンジルアルコ−ルの製法
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).
ES2031407A6 (es) 1988-10-05 1992-12-01 Lasa Lab Mejoras introducidas en el objeto de la patente principal n{ 8703715 por: procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2-((2-(4-metoxifenil)-1-metiletil)amino)etil)fenil)formamida".
ES2208772T3 (es) 1996-01-10 2004-06-16 Asahi Kasei Kabushiki Kaisha Nuevos compuestos triciclicos y compuestos farmaceuticos que contienen los mismos.
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
DE69713374T2 (de) 1996-11-11 2003-01-02 Sepracor Inc., Marlborough Verfahren zur herstellung von optisch reinen isomeren des formoterols
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
US20030145850A1 (en) * 2000-03-01 2003-08-07 Hailey Mark Andrew Metered dose inhaler
US6472563B1 (en) * 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
US7718822B2 (en) * 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer

Also Published As

Publication number Publication date
US8173829B2 (en) 2012-05-08
CA2696922A1 (en) 2009-03-05
AR071045A1 (es) 2010-05-26
WO2009029717A1 (en) 2009-03-05
EP2190813A1 (en) 2010-06-02
KR20100065303A (ko) 2010-06-16
TWI465416B (zh) 2014-12-21
CA2696922C (en) 2015-10-06
US20090060917A1 (en) 2009-03-05
NZ583202A (en) 2012-03-30
AU2008293444B2 (en) 2013-11-21
JP2010538009A (ja) 2010-12-09
JP5529740B2 (ja) 2014-06-25
AU2008293444A1 (en) 2009-03-05
ES2430338T3 (es) 2013-11-20
US7718822B2 (en) 2010-05-18
US20100215589A1 (en) 2010-08-26
EP2190813B1 (en) 2013-07-31
TW200920725A (en) 2009-05-16

Similar Documents

Publication Publication Date Title
MX2010004493A (es) Compuestos de tropano.
MX2009009492A (es) Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas.
PE20091010A1 (es) Derivados de tetrahidroquinolina
EP2662352A3 (en) Method for Producing Phenylacetamide Compound
WO2008075068A3 (en) Acylaminopyrazoles as fgfr inhibitors
WO2009025239A1 (ja) 新規外用剤
WO2010003133A3 (en) Cdk modulators
MX2010004435A (es) Compuestos espiro y uso farmaceutico de los mismos.
GB0418900D0 (en) Novel salt forms
WO2009141718A3 (en) Process for the preparation of prostaglandin analogues and intermediates thereof
MXPA05005139A (es) Nuevo proceso para la sintesis de (1s)-4,5-dimetoxi-1-(metilaminometil)-benzociclobutano y sales de adicion del mismo, y aplicacion en la sintesis de ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.
WO2007109251A3 (en) Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
WO2013062790A3 (en) Ascophyllum nodosum animal chews
JO2893B1 (en) Chemical method
MX2010001978A (es) Estereoisomero de acetamida.
MX2008013520A (es) Agonistas del receptor de adenosina a3.
PT1753723E (pt) Derivados de quinolina substituída como inibidores de quinesina mitótica
MY146245A (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX2010001938A (es) Metodos para preparar compuestos basados en 4-fenil-6-(2,2,2-trifl uoro-1-feniletoxi)pirimidina.
MX2010002039A (es) Estereoisomero de carbamato.
TW200720366A (en) Process for preparing metal compounds of an azo compound in the presence of seed crystals
IT1390756B1 (it) Processo per la sintesi di carbapenem mediante l'uso di nickel raney
WO2010014798A3 (en) Pyrimidotriazinediones and pyrimidopyrimidinediones and methods of using the same
EA200901088A1 (ru) Способ получения 5-бензилокси-2-(4-бензилоксифенил)-3-метил-1н-индола
TW200714584A (en) Method of preparation of maob inhibitors

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration